LEADER 01284oam  2200325z- 450 
001 9910689311103321
005 20161209075446.0
035   $a(CKB)5470000000936120
035   $a(WsH)cbhnovcbhzfb
035   $a(BIP)006472296
035   $a(EXLCZ)995470000000936120
100   $a20211006c2000uuuu  -u-         -
101 0 $aeng
200 10$aAnthrax vaccine adverse reactions $ehearing before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, July 21, 1999
215   $a1 online resource (88 p.) 
311   $a0-16-061136-9 
517   $aAnthrax vaccine adverse reactions 
606   $aAnthrax$xVaccination$zUnited States
606   $aVaccination$xComplications$zUnited States
610   $aAnthrax
610   $aVaccination
610   $aMedical
615  0$aAnthrax$xVaccination
615  0$aVaccination$xComplications
676   $a614.5/61
712 02$aU. S. Congress House Committee on Government Reform Subcommittee on National Security, Veterans Affairs, and International Relations Staff,$4oth
906   $aBOOK
912   $a9910689311103321
996   $aAnthrax vaccine adverse reactions$93182794
997   $aUNINA